Literature DB >> 20417413

Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference.

Anna Laura Ross1, Andreas Bråve, Gabriella Scarlatti, Amapola Manrique, Luigi Buonaguro.   

Abstract

The search for an HIV/AIDS vaccine is steadily moving ahead, generating and validating new concepts in terms of novel vectors for antigen delivery and presentation, new vaccine and adjuvant strategies, alternative approaches to design HIV-1 antigens for eliciting protective cross-neutralising antibodies, and identification of key mechanisms in HIV infection and modulation of the immune system. All these different perspectives are contributing to the unprecedented challenge of developing a protective HIV-1 vaccine. The high scientific value of this massive effort is its great impact on vaccinology as a whole, providing invaluable scientific information for the current and future development of new preventive vaccine as well as therapeutic knowledge-based infectious-disease and cancer vaccines. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20417413     DOI: 10.1016/S1473-3099(10)70069-4

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  20 in total

1.  Can HIV p24 be a suitable scaffold for presenting Env antigens?

Authors:  Luigi Buonaguro; Maria Tagliamonte; Maria Lina Tornesello; Franco M Buonaguro
Journal:  Clin Vaccine Immunol       Date:  2011-09-07

2.  Eliciting neutralizing antibodies with gp120 outer domain constructs based on M-group consensus sequence.

Authors:  Yali Qin; Marisa Banasik; SoonJeung Kim; Adam Penn-Nicholson; Habtom H Habte; Celia LaBranche; David C Montefiori; Chong Wang; Michael W Cho
Journal:  Virology       Date:  2014-08       Impact factor: 3.616

3.  Synthesis of a trimeric gp120 epitope mimic conjugated to a T-helper peptide to improve antigenicity.

Authors:  Joan G Schellinger; Lieza M Danan-Leon; Jessica A Hoch; Aemro Kassa; Indresh Srivastava; David Davis; Jacquelyn Gervay-Hague
Journal:  J Am Chem Soc       Date:  2011-02-22       Impact factor: 15.419

4.  Epitope-focused immunogens against the CD4-binding site of HIV-1 envelope protein induce neutralizing antibodies against auto- and heterologous viruses.

Authors:  Hua Wang; Xiangjun Chen; Dianhong Wang; Chen Yao; Qian Wang; Jiayu Xie; Xuanling Shi; Ye Xiang; Wanli Liu; Linqi Zhang
Journal:  J Biol Chem       Date:  2017-11-29       Impact factor: 5.157

5.  The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigens.

Authors:  Carmen Elena Gómez; José Luis Nájera; Beatriz Perdiguero; Juan García-Arriaza; Carlos Oscar S Sorzano; Victoria Jiménez; Rubén González-Sanz; José Luis Jiménez; María Angeles Muñoz-Fernández; Juan Carlos López Bernaldo de Quirós; Alberto C Guardo; Felipe García; José M Gatell; Montserrat Plana; Mariano Esteban
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

6.  Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania.

Authors:  Muhammad Bakari; Said Aboud; Charlotta Nilsson; Joel Francis; Deus Buma; Candida Moshiro; Eric A Aris; Eligius F Lyamuya; Mohamed Janabi; Karina Godoy-Ramirez; Agricola Joachim; Victoria R Polonis; Andreas Bråve; Patricia Earl; Merlin Robb; Mary Marovich; Britta Wahren; Kisali Pallangyo; Gunnel Biberfeld; Fred Mhalu; Eric Sandström
Journal:  Vaccine       Date:  2011-08-22       Impact factor: 3.641

Review 7.  Profiling immunity to HIV vaccines with systems biology.

Authors:  Erica Andersen-Nissen; Antje Heit; M Juliana McElrath
Journal:  Curr Opin HIV AIDS       Date:  2012-01       Impact factor: 4.283

Review 8.  Dynamics of innate immunity are key to chronic immune activation in AIDS.

Authors:  Arndt Benecke; Michael Gale; Michael G Katze
Journal:  Curr Opin HIV AIDS       Date:  2012-01       Impact factor: 4.283

Review 9.  Induction of immunity to human immunodeficiency virus type-1 by vaccination.

Authors:  M Juliana McElrath; Barton F Haynes
Journal:  Immunity       Date:  2010-10-29       Impact factor: 31.745

10.  HIV p24 as scaffold for presenting conformational HIV Env antigens.

Authors:  Maria Tagliamonte; Daniela Marasco; Alessia Ruggiero; Angelo De Stradis; Maria Lina Tornesello; Maxim Totrov; Franco Maria Buonaguro; Luigi Buonaguro
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.